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ANNOUNCEMENT 
Cutaneous Malignancies: 1994 Skin Cancer Update will be held Friday to Sunday, January 
21-23, 1994, sponsored by Scripps Clinic and Research Fou ndation, at the Sheraton Grande 
Torrey Pines Hotel, La Jolla, California. 
This course is designed for dermatologists, oculoplastic surgeons and ophthal mologists, head 
and neck surgeons, plastic surgeons, fami ly practice physicians , and other physicians with an 
interest in skin cancers. This course w ill provide an update on cutaneous neoplasms, melanoma, 
and facial reconstruction. The combination oflectures and optional hands on cadaver laboratory 
sessions wi ll expose the attendee to the latest information and tech niques. The course will offer 
17 hours of category I CME credit. 
For further information contact Department of Academic Affairs , 403C, Scripps Cli nic and 
Research Foundation, 10666 N . Torrey Pines Road, La Jolla, CA 92037. Telephone: (619) 
554-8556; FAX: (619) 554-6310. 
